Evercore ISI Group downgraded the stock for CRISPR Therapeutics AG (NASDAQ: CRSP) from Outperform to In-Line. For the third quarter, CRISPR ...
Source link
Evercore ISI Group downgraded the stock for CRISPR Therapeutics AG (NASDAQ: CRSP) from Outperform to In-Line. For the third quarter, CRISPR ...
Source link